Cargando…

Hepatic Iron in African Americans Who Underwent Liver Biopsy

BACKGROUND: Primary iron overload in African Americans has been reported predominantly from autopsy studies. METHODS: We characterized hepatic iron phenotypes in 83 African Americans who underwent liver biopsy during the interval 1990 to 1995. We tabulated pathology report form data, iron grades in...

Descripción completa

Detalles Bibliográficos
Autores principales: Barton, James C., Bertoli, Luigi F., Alford, Thomas J., Barton, J. Clayborn, Edwards, Corwin Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Journal of the Medical Sciences 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281163/
https://www.ncbi.nlm.nih.gov/pubmed/25559280
http://dx.doi.org/10.1097/MAJ.0000000000000389
_version_ 1782350952384167936
author Barton, James C.
Bertoli, Luigi F.
Alford, Thomas J.
Barton, J. Clayborn
Edwards, Corwin Q.
author_facet Barton, James C.
Bertoli, Luigi F.
Alford, Thomas J.
Barton, J. Clayborn
Edwards, Corwin Q.
author_sort Barton, James C.
collection PubMed
description BACKGROUND: Primary iron overload in African Americans has been reported predominantly from autopsy studies. METHODS: We characterized hepatic iron phenotypes in 83 African Americans who underwent liver biopsy during the interval 1990 to 1995. We tabulated pathology report form data, iron grades in hepatocytes (0–4) and Kupffer cells (0–3) and abnormal liver histology. Increased iron was defined as hepatocyte or Kupffer iron grades ≥2, respectively. Heavy iron was defined as hepatocyte iron grade 3 or 4. Primary iron overload was defined as the presence of grade 3 or 4 hepatocellular iron in the absence of evidence of chronic alcohol effect, viral hepatitis, steatosis, unexplained inflammation, chronic erythrocyte transfusion or chronic ingestion of iron supplements. RESULTS: There were 37 men and 46 women (mean age: 53 ± 15 [SD] years). We observed heavy ethanol consumption, 12.0%; viral hepatitis, 26.5%; steatosis without heavy ethanol consumption, 43.4%; inflammation, 45.6%; fibrosis, 26.2% and bridging fibrosis/cirrhosis, 29.4%. Logistic regression on bridging fibrosis/cirrhosis revealed positive associations with heavy ethanol consumption (P = 0.0410) and viral hepatitis (P = 0.0044). The 22 patients (26.5%) with increased iron had greater mean age, proportion of men and heavy ethanol consumption. Five patients had heavy iron staining, among whom were 3 women (mean age: 54 years) with primary iron overload. Two of the 3 women had cirrhosis and diabetes mellitus. CONCLUSIONS: Among 83 adult African Americans who underwent liver biopsy, 3.6% had hepatic iron phenotypes consistent with primary iron overload.
format Online
Article
Text
id pubmed-4281163
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The American Journal of the Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-42811632015-01-08 Hepatic Iron in African Americans Who Underwent Liver Biopsy Barton, James C. Bertoli, Luigi F. Alford, Thomas J. Barton, J. Clayborn Edwards, Corwin Q. Am J Med Sci Clinical Investigation BACKGROUND: Primary iron overload in African Americans has been reported predominantly from autopsy studies. METHODS: We characterized hepatic iron phenotypes in 83 African Americans who underwent liver biopsy during the interval 1990 to 1995. We tabulated pathology report form data, iron grades in hepatocytes (0–4) and Kupffer cells (0–3) and abnormal liver histology. Increased iron was defined as hepatocyte or Kupffer iron grades ≥2, respectively. Heavy iron was defined as hepatocyte iron grade 3 or 4. Primary iron overload was defined as the presence of grade 3 or 4 hepatocellular iron in the absence of evidence of chronic alcohol effect, viral hepatitis, steatosis, unexplained inflammation, chronic erythrocyte transfusion or chronic ingestion of iron supplements. RESULTS: There were 37 men and 46 women (mean age: 53 ± 15 [SD] years). We observed heavy ethanol consumption, 12.0%; viral hepatitis, 26.5%; steatosis without heavy ethanol consumption, 43.4%; inflammation, 45.6%; fibrosis, 26.2% and bridging fibrosis/cirrhosis, 29.4%. Logistic regression on bridging fibrosis/cirrhosis revealed positive associations with heavy ethanol consumption (P = 0.0410) and viral hepatitis (P = 0.0044). The 22 patients (26.5%) with increased iron had greater mean age, proportion of men and heavy ethanol consumption. Five patients had heavy iron staining, among whom were 3 women (mean age: 54 years) with primary iron overload. Two of the 3 women had cirrhosis and diabetes mellitus. CONCLUSIONS: Among 83 adult African Americans who underwent liver biopsy, 3.6% had hepatic iron phenotypes consistent with primary iron overload. The American Journal of the Medical Sciences 2015-01 2014-12-30 /pmc/articles/PMC4281163/ /pubmed/25559280 http://dx.doi.org/10.1097/MAJ.0000000000000389 Text en Copyright © 2014 by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Clinical Investigation
Barton, James C.
Bertoli, Luigi F.
Alford, Thomas J.
Barton, J. Clayborn
Edwards, Corwin Q.
Hepatic Iron in African Americans Who Underwent Liver Biopsy
title Hepatic Iron in African Americans Who Underwent Liver Biopsy
title_full Hepatic Iron in African Americans Who Underwent Liver Biopsy
title_fullStr Hepatic Iron in African Americans Who Underwent Liver Biopsy
title_full_unstemmed Hepatic Iron in African Americans Who Underwent Liver Biopsy
title_short Hepatic Iron in African Americans Who Underwent Liver Biopsy
title_sort hepatic iron in african americans who underwent liver biopsy
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281163/
https://www.ncbi.nlm.nih.gov/pubmed/25559280
http://dx.doi.org/10.1097/MAJ.0000000000000389
work_keys_str_mv AT bartonjamesc hepaticironinafricanamericanswhounderwentliverbiopsy
AT bertoliluigif hepaticironinafricanamericanswhounderwentliverbiopsy
AT alfordthomasj hepaticironinafricanamericanswhounderwentliverbiopsy
AT bartonjclayborn hepaticironinafricanamericanswhounderwentliverbiopsy
AT edwardscorwinq hepaticironinafricanamericanswhounderwentliverbiopsy